News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Daily News Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide Yael L. Maxwell July 10, 2024
News Daily News ECG Abnormalities on Routine Screening Tied to CVD Events in Large Study Todd Neale July 05, 2024
News Daily News Despite Gains, Black Americans Still Face Higher CV Mortality Yael L. Maxwell June 19, 2024
News Conference News ACC 2024 HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players Michael O'Riordan April 15, 2024
News Daily News FDA Approves Aprocitentan for Inadequately Controlled Hypertension Michael O'Riordan March 20, 2024
News Daily News US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users Caitlin E. Cox March 18, 2024
News Daily News Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER Michael O'Riordan February 08, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden Caitlin E. Cox December 12, 2023
News Conference News AHA 2023 Sudden Cardiac Death Declining Among NCAA Athletes Michael O'Riordan November 15, 2023
News Conference News AHA 2023 AI Improves Detection of Cardiomyopathy in Pregnancy L.A. McKeown November 15, 2023
News Daily News For Predicting CV Risk, Life’s Essential 8 Doesn’t Add Much to Simple 7 Caitlin E. Cox October 23, 2023
News Daily News Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs Michael O'Riordan July 11, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023